Differences between CCR9 pharmacological inhibition and genetic deletion have also been reported in the TNF-ΔARE ileitis model: pharmacological inhibition of CCR9 [12] was beneficial, whereas CCR9 deletion either had no effect [36] or worsened disease [37]. The gene discussed is TNF; the disease is Crohn ileitis.